APA (7th ed.) Citation

Brouwers, M., Troutt, J., van Greevenbroek, M., Ferreira, I., Feskens, E., van der Kallen, C., . . . Stehouwer, C. (2011). Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study. Atherosclerosis, 217(1), 263-267. https://doi.org/10.1016/j.atherosclerosis.2011.03.023

Chicago Style (17th ed.) Citation

Brouwers, M.C.G.J, et al. "Plasma Proprotein Convertase Subtilisin Kexin Type 9 Is Not Altered in Subjects with Impaired Glucose Metabolism and Type 2 Diabetes Mellitus, but Its Relationship with Non-HDL Cholesterol and Apolipoprotein B May Be Modified by Type 2 Diabetes Mellitus: The CODAM Study." Atherosclerosis 217, no. 1 (2011): 263-267. https://doi.org/10.1016/j.atherosclerosis.2011.03.023.

MLA (9th ed.) Citation

Brouwers, M.C.G.J, et al. "Plasma Proprotein Convertase Subtilisin Kexin Type 9 Is Not Altered in Subjects with Impaired Glucose Metabolism and Type 2 Diabetes Mellitus, but Its Relationship with Non-HDL Cholesterol and Apolipoprotein B May Be Modified by Type 2 Diabetes Mellitus: The CODAM Study." Atherosclerosis, vol. 217, no. 1, 2011, pp. 263-267, https://doi.org/10.1016/j.atherosclerosis.2011.03.023.